Merit Capital Expenditures vs Issuance Of Capital Stock Analysis
MMSI Stock | USD 105.33 0.30 0.29% |
Merit Medical financial indicator trend analysis is infinitely more than just investigating Merit Medical Systems recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Merit Medical Systems is a good investment. Please check the relationship between Merit Medical Capital Expenditures and its Issuance Of Capital Stock accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Capital Expenditures vs Issuance Of Capital Stock
Capital Expenditures vs Issuance Of Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Merit Medical Systems Capital Expenditures account and Issuance Of Capital Stock. At this time, the significance of the direction appears to have no relationship.
The correlation between Merit Medical's Capital Expenditures and Issuance Of Capital Stock is 0.02. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Issuance Of Capital Stock in the same time period over historical financial statements of Merit Medical Systems, assuming nothing else is changed. The correlation between historical values of Merit Medical's Capital Expenditures and Issuance Of Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Merit Medical Systems are associated (or correlated) with its Issuance Of Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Issuance Of Capital Stock has no effect on the direction of Capital Expenditures i.e., Merit Medical's Capital Expenditures and Issuance Of Capital Stock go up and down completely randomly.
Correlation Coefficient | 0.02 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Capital Expenditures
Capital Expenditures are funds used by Merit Medical Systems to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Merit Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Issuance Of Capital Stock
Most indicators from Merit Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Merit Medical Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. As of now, Merit Medical's Enterprise Value is increasing as compared to previous years.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 406.9M | 418.0M | 459.9M | 482.9M | Cost Of Revenue | 589.4M | 631.9M | 673.5M | 707.2M |
Merit Medical fundamental ratios Correlations
Click cells to compare fundamentals
Merit Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Merit Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.8B | 1.7B | 1.6B | 1.7B | 2.3B | 2.4B | |
Short Long Term Debt Total | 523.7M | 435.1M | 315.0M | 268.8M | 891.4M | 935.9M | |
Other Current Liab | 108.0M | 99.0M | 148.3M | 112.2M | 120.4M | 126.5M | |
Total Current Liabilities | 181.7M | 185.0M | 236.3M | 220.6M | 203.6M | 213.7M | |
Total Stockholder Equity | 949.9M | 958.6M | 1.0B | 1.1B | 1.2B | 1.3B | |
Property Plant And Equipment Net | 459.0M | 461.0M | 437.6M | 448.2M | 446.6M | 468.9M | |
Net Debt | 479.4M | 378.2M | 247.3M | 210.3M | 302.2M | 317.3M | |
Retained Earnings | 368.2M | 357.8M | 406.3M | 480.8M | 575.2M | 603.9M | |
Non Current Assets Total | 1.3B | 1.2B | 1.2B | 1.1B | 1.2B | 1.3B | |
Net Receivables | 168.5M | 158.0M | 172.8M | 178.4M | 189.3M | 198.7M | |
Common Stock Shares Outstanding | 56.2M | 55.4M | 57.4M | 57.7M | 58.4M | 39.5M | |
Liabilities And Stockholders Equity | 1.8B | 1.7B | 1.6B | 1.7B | 2.3B | 2.4B | |
Non Current Liabilities Total | 625.7M | 520.8M | 372.2M | 298.9M | 919.7M | 965.7M | |
Inventory | 225.7M | 198.0M | 221.9M | 266.0M | 303.9M | 319.1M | |
Other Current Assets | 12.5M | 16.8M | 19.7M | 26.2M | 26.2M | 27.5M | |
Other Stockholder Equity | (294K) | (5.5M) | (8.0M) | (11.6M) | (1.0) | (0.95) | |
Total Liab | 807.4M | 705.8M | 608.5M | 519.6M | 1.1B | 1.2B | |
Property Plant And Equipment Gross | 459.0M | 461.0M | 652.3M | 686.2M | 775.6M | 814.4M | |
Total Current Assets | 454.5M | 429.7M | 482.2M | 529.1M | 1.1B | 1.2B | |
Accumulated Other Comprehensive Income | (5.3M) | (5.5M) | (8.0M) | (11.6M) | (11.3M) | (10.8M) | |
Short Term Debt | 19.1M | 33.3M | 29.8M | 33.3M | 12.1M | 10.5M | |
Intangible Assets | 445.3M | 367.9M | 319.3M | 275.9M | 325.9M | 342.2M | |
Cash | 44.3M | 56.9M | 67.8M | 58.4M | 589.1M | 618.6M | |
Cash And Short Term Investments | 44.3M | 56.9M | 67.8M | 58.4M | 589.1M | 618.6M | |
Accounts Payable | 54.6M | 49.8M | 55.6M | 68.5M | 65.9M | 69.2M | |
Non Currrent Assets Other | 24.3M | 25.6M | 26.7M | 28.8M | 32.3M | 33.9M | |
Common Stock Total Equity | 587.0M | 606.2M | 641.5M | 675.2M | 776.5M | 815.3M | |
Common Stock | 587.0M | 606.2M | 641.5M | 675.2M | 638.2M | 670.1M | |
Other Liab | 120.7M | 102.7M | 76.3M | 52.4M | 60.3M | 35.4M | |
Other Assets | 28.1M | 227.7M | 47.5M | 31.9M | 36.7M | 25.7M | |
Long Term Debt | 432.0M | 343.7M | 234.4M | 186.8M | 823.0M | 864.2M | |
Good Will | 353.2M | 363.5M | 361.7M | 359.8M | 382.2M | 401.4M | |
Property Plant Equipment | 459.0M | 382.7M | 437.6M | 383.0M | 440.4M | 462.4M | |
Net Tangible Assets | 151.4M | 227.1M | 358.8M | 508.7M | 585.0M | 614.3M | |
Long Term Debt Total | 432.0M | 343.7M | 234.4M | 186.8M | 214.8M | 281.4M | |
Long Term Investments | 17.1M | 12.0M | 14.7M | 15.6M | 19.1M | 12.1M |
Currently Active Assets on Macroaxis
When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Earnings Share 2.05 | Revenue Per Share 22.847 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0456 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.